ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,998Medicare Part D Prescriptions Filled, Including Refills

Rank: 134 out of 783

$716K Total Retail Price of All Prescriptions

Rank: 130 out of 783

710 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
3% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 710 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 11,433 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
AMLODIPINE BESYLATE 649 637 1 5
SIMVASTATIN 626 601 2 3
LEVOTHYROXINE SODIUM 544 517 3 1
LISINOPRIL 350 330 4 4
ATORVASTATIN CALCIUM 337 328 5 11
OMEPRAZOLE 319 299 6 6
METOPROLOL SUCCINATE 266 260 7 13
ATENOLOL 239 221 8 17
SERTRALINE HCL 237 234 9 22
LOSARTAN-HYDROCHLOROTHIAZIDE 208 207 10 53
FUROSEMIDE 207 199 11 7
LOSARTAN POTASSIUM 207 188 11 18
CITALOPRAM HBR 182 164 13 19
HYDROCODONE-ACETAMINOPHEN 181 179 S3 14 2
HYDROCHLOROTHIAZIDE 180 179 15 12
WARFARIN SODIUM 177 164 16 10
TAMSULOSIN HCL 164 163 17 26
CRESTOR 163 140 18 27
ALENDRONATE SODIUM 153 153 19 25
PRAVASTATIN SODIUM 152 151 20 14
METFORMIN HCL 150 144 21 8
TRIAMTERENE-HCTZ 144 137 22 42
GLIPIZIDE ER 144 140 22 84
METOPROLOL TARTRATE 143 137 24 9
ZOLPIDEM TARTRATE 136 132 25 23
ALLOPURINOL 121 111 26 31
MELOXICAM 115 115 27 37
FLUTICASONE PROPIONATE 115 112 27 46
DIOVAN 114 96 29 49
FLUOXETINE HCL 112 100 30 45
POTASSIUM CHLORIDE 108 108 31 16
GABAPENTIN 106 90 32 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 98 97 33 33
DIOVAN HCT 92 89 34 94
ZETIA 87 82 35 80
DONEPEZIL HCL 86 86 36 24
ADVAIR DISKUS 85 83 37 50
EVISTA 84 83 38 92
JANUVIA 83 74 39 73
LIPITOR 81 80 40 114
CYMBALTA 78 78 41 35
TRAMADOL HCL 77 73 42 20
PANTOPRAZOLE SODIUM 76 74 43 30
SYNTHROID 76 73 43 47
NEXIUM 73 73 45 28
KLOR-CON M20 71 50 46 48
CELEBREX 66 65 47 93
RAMIPRIL 60 59 48 113
AMOXICILLIN 60 58 48 116
ATENOLOL-CHLORTHALIDONE 57 44 50 213
CLOPIDOGREL 56 56 51 29
FENOFIBRATE 56 55 51 66
AZITHROMYCIN 54 51 53 41
CARVEDILOL 52 52 54 21
MIRTAZAPINE 51 49 55 52
CYCLOBENZAPRINE HCL 50 50 R 56 63
GLIPIZIDE XL 50 48 56 260
BENICAR HCT 50 50 56 201
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 27, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.